Episode

Financial Market Preview - Monday 27-Jul

Podcast
FactSet U.S. Daily Market Preview
Published
Jul 27, 2026
Duration seconds
372
Processing state
not_requested
Canonical source
https://www.factset.com/podcasts
Audio
https://episodes.captivate.fm/episode/39bde639-0f08-4140-b352-ac489c801287.mp3
JSON
/v1/public/podcasts/factset-u-s-daily-market-preview-128793/episodes/financial-market-preview-monday-27-jul
Markdown
/podcast/factset-u-s-daily-market-preview-128793/financial-market-preview-monday-27-jul.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/factset-u-s-daily-market-preview-128793/episodes/financial-market-preview-monday-27-jul/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/factset-u-s-daily-market-preview-128793/financial-market-preview-monday-27-jul.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

US equity futures are pointing higher, with S&P 500 contracts up 0.8% as markets look to recover after US equities posted their second consecutive negative week. Bonds are firming across the board, with the US 10-year yield falling 5 bps to 4.6%, Bunds down around 4 bps to 3.1%, and Gilts leading the move lower, dropping roughly 7 bps to almost 5%. In commodities, WTI crude is down sharply—off about 5.5% to around $84/bbl—following a revival in Middle East diplomatic efforts, while Brent is trading near $91/bbl. The US dollar is weakening slightly, pulling back from three-week highs, and precious metals are catching a bid with both gold and silver trading higher. Bitcoin is also rebounding. Risk appetite is recovering as markets latch onto a fragile Middle East truce. The US-military paused attacks on Iran amid ammunition shortages, with Tehran reciprocating, though the Houthis struck Saudi oil facilities in the interim. Investors are treating the pause as a broader de-escalation signal, sending Brent crude sharply lower. Companies Mentioned: DCC Energy, Argenx, Forte Biosciences, Carlyle Group, Bain Capital